FDA approves first generic version of drug that made Martin Shkreli infamous

(By Maia Anderson for Becker’s Hospital Review)

The FDA approved Feb. 28 the first generic version of Daraprim, the lifesaving drug for which Martin Shkreli became infamous by raising the price by 4,000 percent overnight.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.